テネシーにおけるアルツハイマー病の臨床試験
テネシー内の拠点で、アルツハイマー病に関する16件の研究が参加者を募集しています。
テネシー内の都市
公式研究テキスト（英語）
Randomized Study to Evaluate the Effect of Obicetrapib in Participants With Preclinical Alzheimer's Disease
- K2 Medical Research, Nashville
被験者募集中第2相
55歳〜85歳 · 全性別 · 2026/09/28更新 · NCT07794670A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Neurology Clinic, P.C., Cordova
被験者募集中第4相
50歳以上 · 全性別 · 2026/09/25更新 · NCT07633470A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Vanderbilt Psychiatric Hospital, Nashville
被験者募集中第3相
55歳〜90歳 · 全性別 · 2026/09/22更新 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- K2 Medical Research Nashville LLC, Nashville
被験者募集中第2相
55歳〜80歳 · 全性別 · 2026/09/21更新 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Genesis Neuroscience Clinic, Knoxville
- K2 Medical Research - Nashville, Nashville
被験者募集中第3相
50歳〜90歳 · 全性別 · 2026/09/21更新 · NCT07177352A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
- Neurology Clinic - Cordova /ID# 277790, Cordova
被験者募集中第1/2相
50歳〜90歳 · 全性別 · 2026/09/18更新 · NCT07599670Alzheimer's Tau Platform: Master Protocol
- Vanderbilt University Medical Center, Nashville
被験者募集中第2相
50歳〜80歳 · 全性別 · 2026/09/08更新 · NCT06957418Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0031, Chattanooga
- Neurology Clinic, P.C., Cordova
- Vanderbilt University Medical Center- Village, Nashville
被験者募集中第2相
55歳〜90歳 · 全性別 · 2026/09/01更新 · NCT06808984A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Neurology Clinic, P.C., Cordova
被験者募集中第3相
60歳〜85歳 · 全性別 · 2026/08/20更新 · NCT06976216A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
- Neurology Clinical, P.C., Cordova
被験者募集中第1/2相
35歳〜85歳 · 全性別 · 2026/07/10更新 · NCT05462106Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition
- Vanderbilt University Medical Center Clinical Research Center, Nashville
被験者募集中第2相健康なボランティア歓迎
18歳〜55歳 · 全性別 · 2026/06/22更新 · NCT05231798Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Vanderbilt University Medical Center Center for Cognitive Medicine, Nashville
被験者募集中観察研究
25歳〜55歳 · 全性別 · 2026/05/18更新 · NCT04165109Swallowing Impairments in Adults With and Without Alzheimer's Disease
- Vanderbilt University Medical Center, Nashville
被験者募集中観察研究健康なボランティア歓迎
60歳以上 · 全性別 · 2026/05/08更新 · NCT06678100Tennessee Alzheimer's Project
- Vanderbilt University Medical Center, Nashville
被験者募集中観察研究健康なボランティア歓迎
60歳以上 · 全性別 · 2026/02/05更新 · NCT05372172Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
- Cumberland Medical Center, Crossville
- Roane Medical Center, Harriman
- Fort Sanders Regional Medical Center, Knoxville
- 他3件
被験者募集中
60歳〜90歳 · 全性別 · 2025/10/29更新 · NCT07222280Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
- National HealthCare Corporation, Murfreesboro
被験者募集中
50歳以上 · 全性別 · 2024/03/12更新 · NCT05820919ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。